argenx SE
broad opportunity by targeting phase healthy volunteer data expected mid phase indications and formulations unique intervention | argenx SE
Company
Deck Type
Sector
Industry
Deck date
March 2021
Slide
12 of 20
Similar slides by argenx SE
See diffirences between slides (animation)
Results
May 2021
broad opportunity by targeting phase healthy volunteer data expected mid phase indications unique intervention | argenx SE
Related slides by other companies
Synchrony Financial
Investor Day
September 2021
deep and broad opportunity to gain market share i | Synchrony Financial
23andMe
Investor Presentation
January 2024
next steps | 23andMe
NeuroSense Therapeutics
Investor Presentation
December 2023
phase trial | NeuroSense Therapeutics
NextNav
SPAC
September 2021
is targeting a billion market today | NextNav
Other recent decks by argenx SE
See all presentations (28 decks)
Results
February 2024
Investor Conference
January 2024
Investor Presentation
December 2023
Investor Presentation
November 2023
Search Thousands of Presentations by World Leading Companies
Trending:
Addressable Market
Ecosystem
Beauty Market
WACC
NFT
Management Team
Investment Highlights